149498-94-2

Basic information

• Product Name: ETHYL 3-AMINO-3-(1,3-BENZODIOXOL-5-YL)PROPANOATE HYDROCHLORIDE
• Synonyms: BIO-FARMA BF001831;ETHYL 3-AMINO-3-(1,3-BENZODIOXOL-5-YL)PROPANOATE HYDROCHLORIDE;3-AMINO-3-BENZO[1,3]DIOXOL-5-YL-PROPIONIC ACIDETHYL ESTER HYDROCHLORIDE;3-Amino-3-benzo[1,3]dioxol-5-yl-propionic acid ethyl ester, HCl
• CAS NO: 149498-94-2
• Molecular Formula: C₁₂H₁₅NO₄*ClH
• Molecular Weight: 273.71
• Mol File: 149498-94-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ETHYL 3-AMINO-3-(1,3-BENZODIOXOL-5-YL)PROPANOATE HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 3-AMINO-3-(1,3-BENZODIOXOL-5-YL)PROPANOATE HYDROCHLORIDE(149498-94-2)
• EPA Substance Registry System: ETHYL 3-AMINO-3-(1,3-BENZODIOXOL-5-YL)PROPANOATE HYDROCHLORIDE(149498-94-2)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 149498-94-2(Hazardous Substances Data)

Usage

Uses

3-Amino-3-benzo[1,3]dioxol-5-yl-propionic acid ethyl ester, HCl

Upstream product

• 120-57-0 piperonal 
• 64-17-5 ethanol 
• 129042-60-0 (S)-3-amino-3-(3,4-methylenedioxyphenyl)propionic acid 

Downstream Products

• 149520-08-1 ethyl (R)-3-amino-3-benzo[1,3]dioxol-5-ylpropanoate 
• 72071-75-1 (S)-3-amino-3-(piperon-3-yl)propanoic acid 
• 149519-82-4 ethyl β-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-1,3-benzodioxole-5-propanoate 
• 255720-48-0 ethyl 3-(1,3-benzodioxol-5-yl)-3-{[2-(4-(4-cyano-phenyl)-2-oxopiperazino)acetyl]amino}propanoate 

Relevant articles and documents

An efficient new enzymatic method for the preparation of β-aryl-β-amino acid enantiomers

An efficient synthesis of β-aryl-β-amino acid enantiomers has been developed via the lipase-catalysed enantioselective hydrolysis of the corresponding racemic ethyl esters in an organic solvent. High enantioselectivities (E >100) were observed when the lipase PS-catalysed reactions were performed with H2O (0.5 equiv) in diisopropyl ether at 45 °C. The products could be easily separated and were obtained in good yields of ≥40%.

Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp sequence of fibrinogen. (Aminobenzamidino)succinyl (ABAS) series of orally active fibrinogen receptor antagonists

Our initial orally active fibrinogen receptor antagonist benzamidinopentanoyl (BAP) series which was discovered through truncation of our iv antiplatelet agent (SC-52012) demonstrated modest oral activity in canine studies (ethyl [5-(4-amidinophenyl)penta

Substituted heterocyclic derivatives useful as platelet aggregation inhibitors

Novel substituted heterocyclic derivatives are provided which inhibit platelet aggregation. This invention also pertains to pharmaceutical compositions and methods of using such derivatives.